Compounds of formula (I):
wherein R
2
, W, A, Y, and R
1
are as defined in the specification, and pharmaceutically acceptable salts thereof, are p38 MAPK inhibitors, and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
式(I)的化合物:其中R2、W、A、Y和R1如说明书中所定义的,以及其药学上可接受的盐,是p38
MAPK
抑制剂,可用于治疗呼吸道疾病等炎症相关疾病的抗炎药物。